Skip to content

Frontiers in Psychiatry

ISSN 1664-0640

601 papers in the library · 9,228 citations · publishing 2010-2026

Papers

Sort Most recent Most cited

Case Report: Unexpected Remission From Extreme and Enduring Bulimia Nervosa With Repeated Ketamine Assisted Psychotherapy.

Frontiers in Psychiatry 2021 Anya Ragnhildstveit, Laura Kate Jackson, Sarah Cunningham et al.

Background: Bulimia nervosa is a disabling psychiatric disorder that considerably impairs physical health, disrupts psychosocial functioning, and reduces overall quality of life. Despite available treatment, less than half of sufferers achieve recovery and approximately a third become chronically ill. Extreme and enduring cases are particularly resistant to first-line treatment, namely...

DOI: 10.3389/fpsyt.2021.764112 (opens in new tab) Full text (opens in new tab) Binge-eating Bulimia nervosa Case report Eating disorder +3

Coping With COVID-19: Mindfulness-Based Approaches for Mitigating Mental Health Crisis.

Frontiers in Psychiatry 2021 Elena Antonova, Karoly Schlosser, Rakesh Pandey et al.

The novel coronavirus disease COVID-19 that first emerged in Wuhan, China, in Nov-Dec 2019 has already impacted a significant proportion of the world population. Governments of many countries imposed quarantines and social distancing measures in 2020, many of which remain in place, to mitigate the spread of the SARS-Cov-2 virus causing the COVID-19 disease. The direct impact of COVID-19 on...

Mindfulness-Based Cognitive Therapy in Major Depressive Disorder: A Study Protocol of a Randomized Control Trial and a Case-Control Study With Electroencephalogram.

Frontiers in Psychiatry 2021 Tianran Zhang, Lanlan Wang, Yanle Bai et al.

Background: In this report, a study protocol for a randomized control trial is presented in an attempt to explore the efficacy of mindfulness-based cognitive therapy (MBCT) for major depressive disorder (MMD), and a case-control study is conducted to find the difference in electroencephalograms (EEGs) between MMD and normal controls. Design: Seventy Chinese patients with MMD will be chosen for...

DOI: 10.3389/fpsyt.2021.499633 (opens in new tab) Full text (opens in new tab) Major depressive disorder Case-control study Electroencephalogram Randomized-control trial

Mindfulness-Based Cognitive Therapy for Unmedicated Obsessive-Compulsive Disorder: A Randomized Controlled Trial With 6-Month Follow-Up.

Frontiers in Psychiatry 2021 Tianran Zhang, Lu Lu, Fabrizio Didonna et al.

Background: This was the first randomized controlled trial (RCT) designed to compare the efficacy of mindfulness-based cognitive therapy (MBCT) on unmedicated obsessive-compulsive disorder with that of the first-line treatment for OCD (SSRIs) or a placebo, as well as to analyze the treatment acceptability and safety of MBCT. Methods: A total of 123 unmedicated OCD patients with mild to moderate...

Ketamine Alters Functional Gamma and Theta Resting-State Connectivity in Healthy Humans: Implications for Schizophrenia Treatment Targeting the Glutamate System.

Frontiers in Psychiatry 2021 Stjepan Curic, Christina Andreou, Guido Nolte et al.

Disturbed functional connectivity is assumed to cause neurocognitive deficits in patients suffering from schizophrenia. A Glutamate N-methyl-D-aspartate receptor (NMDAR) dysfunction has been suggested as a possible mechanism underlying altered connectivity in schizophrenia, especially in the gamma- and theta-frequency range. The present study aimed to investigate the effects of the...

DOI: 10.3389/fpsyt.2021.671007 (opens in new tab) Full text (opens in new tab) Functional connectivity Gamma-band oscillations Glutamate hypothesis Negative-symptoms +2

Impact of a Combined Philosophy and Mindfulness Intervention on Positive and Negative Indicators of Mental Health Among Pre-kindergarten Children: Results From a Pilot and Feasibility Study.

Frontiers in Psychiatry December 11, 2020

Background: Fostering greater resiliency to stress, optimal psychosocial development and promoting better mental health and well-being in youth is an important goal of the Canadian and American elementary school systems ( 1 , 2 ). Recent research on mindfulness and philosophy for children (P4C) has yielded promising results regarding innovative interventions that may be implemented in...

Self-Reported Illicit Drug Use Among Norwegian University and College Students. Associations With Age, Gender, and Geography

Frontiers in Psychiatry December 10, 2020 Ove Heradstveit, Jens Christoffer Skogen, Marit Edland-Gryt et al. 19 citations

Background and Aims: Several studies have pointed to relatively high levels of illicit drug use among students in higher education compared to the general population. The aim of the present study was to provide an updated examination of self-reported illicit drug use among Norwegian University and college students. Methods: Data stem from the SHoT study (Students' Health and Well-being Study),...

DOI: 10.3389/fpsyt.2020.543507 (opens in new tab) Norwegian Illicit drug Clinical psychology Demography +1

Evaluating the Use of Mindfulness and Yoga Training on Forensic Inpatients: A Pilot Study.

Frontiers in Psychiatry December 10, 2020 Christina Spinelli, Etienne Paradis-Gagné, Megan Per et al.

Forensic inpatients (i. e., individuals found not responsible for a criminal offense on account of mental illness) represent an often marginalized and difficult-to-treat population. This has led to the need for research exploring the effectiveness of novel interventions. A Canadian forensic hospital has developed an 8-weeks mindfulness and yoga training program (MTP). This pilot study examined...

Commentary: Psychedelic Psychiatry's Brave New World.

Frontiers in Psychiatry November 26, 2020 Bénédicte Nobile, Emilie Olié, Philippe Courtet 2 citations

In their recent article entitled “Psychedelic Psychiatry's Brave New World,” Nutt et al. (1) wrote that new research on psychedelic drugs, especially psilocybin, has highlighted their potential for psychiatric disorder management. In the past decade, many studies focused on psilocybin effects on mood disorders (2) showing that it can significantly improve depressive symptomatology for weeks and...

DOI: 10.3389/fpsyt.2020.594077 (opens in new tab) Full text (opens in new tab) Psychedelic therapy Mental health treatment Clinical integration Innovative psychiatry

Treatment of a Complex Personality Disorder Using Repeated Doses of LSD—A Case Report on Significant Improvements in the Absence of Acute Drug Effects

Frontiers in Psychiatry October 22, 2020 Felix Müller, Markus Mühlhauser, Friederike Holze et al. 31 citations

A 39-year-old female patient suffering from severe, treatment-resistant depression and other symptoms associated with a complex personality disorder was admitted to our open psychiatric ward for an experimental treatment with lysergic acid diethylamide (LSD). The substance was administered in repeated weekly and ascending doses. Curiously, there were no substantial acute subjective effects of...

Self and the Brain. The Immune Metaphor.

Frontiers in Psychiatry September 29, 2020 Silvia Sánchez-Ramón, Florence Faure

One of the fundamental questions in neuroscience is how brain activity relates to conscious experience. Even though self-consciousness is considered an emergent property of the brain network, a quantum physics-based theory assigns a momentum of consciousness to the single neuron level. In this work, we present a brain self theory from an evolutionary biological perspective by analogy with the...

The Psychonauts’ World of Cognitive Enhancers

Frontiers in Psychiatry September 11, 2020 Flavia Napoletano, Fabrizio Schifano, John Corkery et al. 46 citations

Background: There is growing availability of novel psychoactive substances (NPS), including cognitive enhancers (CEs) which can be used in the treatment of certain mental health disorders. Whilst treating cognitive deficit symptoms in neuropsychiatric or neurodegenerative disorders using CEs might have significant benefits for patients, the increasing recreational use of these substances by...

Effect of Ketamine on Limbic GABA and Glutamate: A Human In Vivo Multivoxel Magnetic Resonance Spectroscopy Study

Frontiers in Psychiatry September 8, 2020 Leo R. Silberbauer, B. Spurny, P. Handschuh et al. 43 citations

Introduction Converging evidence suggests that ketamine elicits antidepressant effects via enhanced neuroplasticity precipitated by a surge of glutamate and modulation of GABA. Magnetic resonance spectroscopic imaging (MRSI) illustrates changes to cerebral glutamate and GABA immediately following ketamine administration during dissociation. However, few studies assess subacute changes in the...

Club Drugs: Psychotropic Effects and Psychopathological Characteristics of a Sample of Inpatients

Frontiers in Psychiatry August 31, 2020 Giovanni Martinotti, Attilio Negri, Stefania Schiavone et al. 22 citations

In this study, we described the acute psychiatric presentations related to recreational drug use in subjects on holiday in Ibiza. The use of psychoactive substances was characterized by poly-use of both traditional and novel substances, with several psychopathological consequences. Future research should focus on a better understanding of the psychopathological effects of specific substances,...

DOI: 10.3389/fpsyt.2020.00879 (opens in new tab) Psychopathology Stimulant Substance abuse Psychoactive substance +1

The Antidepressant Effect of Ketamine Is Dampened by Concomitant Benzodiazepine Medication

Frontiers in Psychiatry August 28, 2020 Veronika Andrashko, Tomáš Novák, Martin Brunovský et al. 46 citations

The rapid antidepressant effect of ketamine has become a breakthrough in the research and treatment of depression. Although predictive and modulating factors of the response to ketamine are broadly studied, little is known about optimal concurrent medication protocols. Concerning gamma-aminobutyric acid neurotransmission being a shared target for both ketamine and benzodiazepines (BZD), we...

Evidence That Cannabis Exposure, Abuse, and Dependence Are Related to Glutamate Metabolism and Glial Function in the Anterior Cingulate Cortex: A 1H-Magnetic Resonance Spectroscopy Study

Frontiers in Psychiatry August 20, 2020 Jeremy J. Watts, Ranjini Garani Ramesh, Tânia Maria Sarmento Silva et al. 21 citations

There is evidence that long-term cannabis use is associated with alterations to glutamate neurotransmission and glial function. In this study, twenty-six long-term cannabis users (males=65.4%) and 47 non-cannabis using healthy controls (males=44.6%) underwent proton magnetic resonance spectroscopy (1H-MRS) of the anterior cingulate cortex (ACC) in order to characterize neurometabolite...

DOI: 10.3389/fpsyt.2020.00764 (opens in new tab) Cannabis Glutamate receptor Glutamine Anterior cingulate cortex +4

Post-Psychedelic Reductions in Experiential Avoidance Are Associated With Decreases in Depression Severity and Suicidal Ideation

Frontiers in Psychiatry August 7, 2020 Richard J. Zeifman, Anne Catherine Wagner, Ros Watts et al. 104 citations

Psychedelic therapy shows promise as a novel intervention for a wide range of mental health concerns but its therapeutic action is incompletely understood. In line with acceptance and commitment therapy's (ACT's) transdiagnostic model, qualitative research has suggested that reductions in experiential avoidance are an important component of therapeutic outcomes associated with psychedelics....

DOI: 10.3389/fpsyt.2020.00782 (opens in new tab) Anxiety Suicidal ideation Experiential avoidance Depression economics +5

Prolonged Remission of Major Depressive Disorder After Single Nitrous Oxide Inhalation Treatment

Frontiers in Psychiatry July 17, 2020 Peter Nagele, Frank Brown, Victoria Bass et al.

Nitrous oxide (N2O, laughing gas) has shown early promise as a rapidly acting treatment for treatmentresistant major depression (1–3). Antidepressant effects of nitrous oxide in these studies started within 2 h and lasted up to 1 week. Due to the study design, however, it was impossible to determine whether antidepressant efficacy lasted beyond 1 week after nitrous oxide administration. There...

Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment

Frontiers in Psychiatry July 7, 2020 Michael Specka, Thomas Kuhlmann, Jürgen Sawazki et al. 42 citations

Background About 15 years ago, a diverse group of new recreational psychotropic substances began to emerge, which were marketed for example as “legal highs,” “research chemicals,” or “designer drugs.” These substances were later subsumed under the label “Novel Psychoactive Substances” (NPS). Important NPS classes are cathinones, synthetic cannabimimetics, phenethylamines, and herbal drugs. The...

Cannabis Use Is Associated With Increased Levels of Soluble gp130 in Schizophrenia but Not in Bipolar Disorder

Frontiers in Psychiatry July 2, 2020 Attila Szabo, Ibrahim A. Akkouh, Thor Ueland et al. 12 citations

The complex effects of plant cannabinoids on human physiology is not yet fully understood, but include a wide spectrum of effects on immune modulation. The immune system and its inflammatory effector pathways are recently emerging as possible causative factors in psychotic disorders. The present study aimed to investigate whether self-administered cannabis use was associated with changes in...

Affective Switch Associated With Oral, Low Dose Ketamine Treatment in a Patient With Treatment Resistant Bipolar I Depression. Case Report and Literature Review

Frontiers in Psychiatry June 3, 2020 Alina Wilkowska, Łukasz P. Szałach, Jakub Słupski et al. 9 citations

There is a growing evidence for the rapid and robust antidepressive effect of ketamine in unipolar and bipolar treatment resistant depression although evidence for the risk of affective switch is still limited. This case presents bipolar I disorder patient with treatment resistant depressive episode experiencing a switch to manic episode with mixed features shortly after receiving eight...

Effects of Yoga Respiratory Practice (Bhastrika pranayama) on Anxiety, Affect, and Brain Functional Connectivity and Activity: A Randomized Controlled Trial

Frontiers in Psychiatry May 21, 2020 Morgana M. Novaes, Fernanda Palhano-Fontes, Heloisa Onias et al. 110 citations

Pranayama refers to a set of yoga breathing exercises. Recent evidence suggests that the practice of pranayama has positive effects on measures of clinical stress and anxiety. This study explored the impact of a Bhastrika pranayama training program on emotion processing, anxiety and affect. We used a randomized controlled trial design with thirty healthy young adults assessed at baseline and...

Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review

Frontiers in Psychiatry March 31, 2020 Kristin Heuschkel, Kim P. C. Kuypers 82 citations

Depression is a major public health problem that affects approximately 4.4% of the global population. Since conventional pharmacotherapies and psychotherapies are only partially effective, as demonstrated by the number of patients failing to achieve remission, alternative treatments are needed. Mindfulness meditation (MM) and psilocybin represent two promising novel treatments that might even...

Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance

Frontiers in Psychiatry February 21, 2020 Max Wolff, Ricarda Evens, Lea J. Mertens et al. 188 citations

The efficacy of psychedelic-assisted therapies for mental disorders has been attributed to the lasting change from experiential avoidance to acceptance that these treatments appear to facilitate. This article presents a conceptual model that specifies potential psychological mechanisms underlying such change, and that shows substantial parallels between psychedelic therapy and cognitive...

DOI: 10.3389/fpsyt.2020.00005 (opens in new tab) Anxiety Experiential avoidance Context archaeology Cognition +5

Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics

Frontiers in Psychiatry February 11, 2020 James D. Sexton, Charles D. Nichols, Peter S. Hendricks 45 citations

IntroductionThe majority of contemporary psychedelic research has focused on ayahuasca, lysergic acid diethylamide, and psilocybin, though there are hundreds of novel psychedelic compounds that may have clinical utility. The purpose of the present study was to evaluate the therapeutic potential of classic and novel phenethylamine, tryptamine, and lysergamide psychedelics via a large, nationally...